COVID: US FDA flags risk of myocarditis from Novavax shot - CTV News

The U.S. Food and Drug Administration has raised concerns about a possible risk of heart inflammation from Novavax Inc.'s COVID-19 vaccine, even as the company's data showed it could reduce the chances of mild-to-severe disease.

Bengaluru India - The U.S. Food and Drug Administration has raised concerns about a possible risk of heart inflammation from Novavax Inc.'s COVID-19 vaccine, even as the company's data showed it co… [+2517 chars]

full article...